Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
1217605-72-5
162758-04-5
304439-23-4
72040-64-3
21788-37-4
111790-37-5
192821-24-2 | (S,S)-(1-Dimethylcarbamoyl-2-methyl-butyl)-carbamic acid tert-butyl ester | AA00ASVZ | MFCD29037636
285979-81-9 | SODIUM EQUILIN-2,4,16,16-D4 SULFATE | AA00BEIS | MFCD06656069
20619-12-9 | N-desmethylchlorpheniramine | AA00BVZL | MFCD21363476
40026-24-2 | 6-Chlorochroman-2-carboxylic acid | AA00C66W | MFCD08669493
342602-87-3 | 5-Bromo-n,n-dimethylpyridin-3-amine | AA00CIW6 | MFCD12828170
37831-31-5 | 3-Acetylpyridin-4(1h)-one | AA00CXV1 | MFCD18834818
4891-71-8 | 9-chloro-6alpha-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-hexanoate | AA00DF6D
547-98-8 | (3a,5b,7a,12a)-3,7,12-trihydroxy-Cholestan-26-oic acid | AA00DM24 | MFCD22416733
647036-07-5 | Cyclic-Oligo Bis[(1R,2R)-(+)-1,2-cyclohexanediaMino-N,N'-bis(3,3'-di-t-butylsalicylidene) cobalt(III)triflate]-5,5'-bis(2-carboxyethyl)ether | AA00EF34 | MFCD28144555
57631-12-6 | 1H-Indazole, 7-broMo-3-(trifluoroMethyl)- | AA00F18Y | MFCD16616665
